MR Grever

1.0k total citations
24 papers, 848 citations indexed

About

MR Grever is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, MR Grever has authored 24 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 7 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in MR Grever's work include Chronic Lymphocytic Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (5 papers) and HIV/AIDS drug development and treatment (4 papers). MR Grever is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (5 papers) and HIV/AIDS drug development and treatment (4 papers). MR Grever collaborates with scholars based in United States and India. MR Grever's co-authors include Balcerzak Sp, Louis Malspeis, JJ Hutton, Deborah Young, FR Appelbaum, Jonathan D. Licht, KJ Kopecky, IM Chen, Ian W. Flinn and Coltman Ca and has published in prestigious journals such as Blood and PubMed.

In The Last Decade

MR Grever

23 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MR Grever United States 12 389 299 292 242 208 24 848
DG Poplack United States 13 135 0.3× 219 0.7× 68 0.2× 213 0.9× 262 1.3× 22 716
Ugo Consoli Italy 17 181 0.5× 367 1.2× 102 0.3× 239 1.0× 395 1.9× 36 863
Yingzhe Yu China 9 117 0.3× 195 0.7× 79 0.3× 215 0.9× 189 0.9× 23 626
Trang Le Austria 16 336 0.9× 475 1.6× 274 0.9× 288 1.2× 179 0.9× 38 988
M Beran United States 14 302 0.8× 335 1.1× 93 0.3× 121 0.5× 209 1.0× 18 812
S Labaume France 13 125 0.3× 326 1.1× 71 0.2× 223 0.9× 79 0.4× 21 696
F. Dreyfus France 15 326 0.8× 462 1.5× 153 0.5× 256 1.1× 441 2.1× 56 1.2k
Katharina Clodi United States 16 105 0.3× 387 1.3× 149 0.5× 324 1.3× 224 1.1× 19 725
Lippman Sm United States 9 125 0.3× 346 1.2× 327 1.1× 165 0.7× 221 1.1× 16 807
Lee Levitt United States 13 85 0.2× 200 0.7× 38 0.1× 183 0.8× 132 0.6× 24 667

Countries citing papers authored by MR Grever

Since Specialization
Citations

This map shows the geographic impact of MR Grever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MR Grever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MR Grever more than expected).

Fields of papers citing papers by MR Grever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MR Grever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MR Grever. The network helps show where MR Grever may publish in the future.

Co-authorship network of co-authors of MR Grever

This figure shows the co-authorship network connecting the top 25 collaborators of MR Grever. A scholar is included among the top collaborators of MR Grever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MR Grever. MR Grever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grever, MR, et al.. (2001). Cytotoxic alkaloids from Tylophora indica.. PubMed. 56(2). 188–90. 11 indexed citations
2.
Grever, MR, et al.. (2000). Theophylline, pentostatin (Nipent), and chlorambucil: a dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders.. PubMed. 27(2 Suppl 5). 37–40. 1 indexed citations
3.
Grever, MR, et al.. (1998). Old and new therapies in chronic lymphocytic leukemia: now is the time for a reassessment of therapeutic goals.. PubMed. 25(1). 65–74. 50 indexed citations
4.
Grever, MR, et al.. (1994). Long-term follow-up of patients with hairy cell leukemia after treatment with 2'-deoxycoformycin. Blood. 84(12). 4061–4063. 71 indexed citations
5.
6.
7.
Malspeis, Louis, et al.. (1990). Pharmacokinetics of 2-F-ara-A (9-beta-D-arabinofuranosyl-2-fluoroadenine) in cancer patients during the phase I clinical investigation of fludarabine phosphate.. PubMed. 17(1 Suppl 3). 18–32. 88 indexed citations
8.
Copelan, EA, et al.. (1988). Pharmacologic marrow purging in murine T cell leukemia. Blood. 71(6). 1656–1661. 3 indexed citations
9.
Grever, MR, et al.. (1987). Treatment of hairy cell leukemia: the Ohio State University experience with deoxycoformycin.. PubMed. 1(4). 350–4. 15 indexed citations
10.
Grever, MR. (1987). Treatment of patients with acute nonlymphocytic leukemia not in remission.. PubMed. 14(4). 416–24. 11 indexed citations
11.
Grever, MR, et al.. (1984). Phase I trial of teroxirone.. PubMed. 68(9). 1115–9. 3 indexed citations
12.
Grever, MR, et al.. (1983). Differential excretion of modified nucleosides in adult acute leukemia. Blood. 61(2). 291–296.
13.
Grever, MR, et al.. (1983). An investigation of 2'-deoxycoformycin in the treatment of cutaneous T- cell lymphoma. Blood. 61(2). 279–282. 82 indexed citations
14.
Grever, MR, et al.. (1983). An investigation of 2'-deoxycoformycin in the treatment of cutaneous T- cell lymphoma. Blood. 61(2). 279–282. 4 indexed citations
15.
Grever, MR, et al.. (1983). Differential excretion of modified nucleosides in adult acute leukemia. Blood. 61(2). 291–296. 23 indexed citations
16.
Sp, Balcerzak, et al.. (1982). Preliminary studies of continuous extracorporeal carbamylation in the treatment of sickle cell anemia.. PubMed. 100(3). 345–55. 5 indexed citations
17.
Grever, MR, et al.. (1982). 2'-deoxycoformycin (DCF) and 9-beta-D-arabinofuranosyladenine (Ara-A) in the treatment of refractory acute myelocytic leukemia.. PubMed. 66(2). 253–7. 6 indexed citations
18.
Grever, MR, et al.. (1981). The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy. Blood. 57(3). 406–417. 180 indexed citations
19.
Grever, MR, et al.. (1981). The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy. Blood. 57(3). 406–417. 6 indexed citations
20.
Grever, MR, et al.. (1980). The effect of oxidant stress on human lymphocyte cytotoxicity. Blood. 56(2). 284–288. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by DG Poplack Breakdown of academic impact, for papers by Ugo Consoli Breakdown of academic impact, for papers by Yingzhe Yu Breakdown of academic impact, for papers by Trang Le Breakdown of academic impact, for papers by M Beran Breakdown of academic impact, for papers by S Labaume Breakdown of academic impact, for papers by F. Dreyfus Breakdown of academic impact, for papers by Katharina Clodi Breakdown of academic impact, for papers by Lippman Sm Breakdown of academic impact, for papers by Lee Levitt
Rankless by CCL
2026